Mubadala Health
Mubadala Health (operating as M42) is an Abu Dhabi-based tech-enabled health company operating 480 facilities across 27 countries, serving 15 million patients annually through integrated clinical care, genomics, AI diagnostics, and digital health platforms.
- Company typePrivate
- Founded2021
- HeadquartersAbu Dhabi, United Arab Emirates
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What Mubadala Health does
Mubadala Health, operating commercially as M42, is a tech-enabled health company headquartered in Abu Dhabi, UAE, founded in 2021. It operates four integrated platforms — Global Patient Care, Digital Health Solutions, Integrated Health Solutions, and AI Life Sciences — supported by specialized sub-brands including IROS (genomics-driven clinical trials), Abu Dhabi Biobank, National Reference Laboratory (NRL), and Amana Healthcare Bahrain. The company runs 480 facilities across 27 countries, employs approximately 20,000 people, and serves 15 million patients annually across 100+ service lines. It is positioned as the No. 1 largest healthcare company in the Middle East and the #3 largest dialysis provider globally, and operates the first centralized Health Information Exchange in the region.
Core technology is built around the integration of genomics, digital health, and AI. Proprietary or partner-enabled capabilities include the Emirati Genome Programme integration, the Abu Dhabi Biobank, Human Virtual Twin simulation technology (with BioTwin), AI-powered digital pathology and prostate cancer diagnostics (with Qritive), and a centralized health information exchange enabling cross-provider data sharing. These support precision medicine, early disease identification, drug discovery, and population-scale health management.
The revenue model combines healthcare service delivery (multi-specialty clinical care, dialysis, diagnostics through NRL, and population health programs under Integrated Health Solutions) with digital health solutions offered to providers and institutions. Go-to-market relies on direct facility operations, enterprise partnerships with government health authorities and research institutions, and channel partnerships with technology vendors. Pricing is contract-negotiated with government, institutional, and insurance counterparties rather than publicly disclosed.
Mubadala Health firmographics
Firmographics- Name
- Mubadala Health
- Legal name
- M42
- Website
- https://mubadalahealth.ae
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Mubadala Health (operating as M42) is an Abu Dhabi-based tech-enabled health company operating 480 facilities across 27 countries, serving 15 million patients annually through integrated clinical care, genomics, AI diagnostics, and digital health platforms.
- Ownership category
- akta.pro rank
Mubadala Health industry classification
Industry- Product category
- Integrated Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (6221), Ambulatory Health Care Services (621), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Hospitals (8060)
- akta.pro primary industry
- Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing) (BPAMAHAH)
- akta.pro secondary industry
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
Keywords
Where Mubadala Health is headquartered
LocationHeadquarters
- HQ city
- Abu Dhabi
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Mubadala Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Healthcare Services Revenue: Revenue generated from providing medical services through 480 clinics and facilities across 27 countries, serving approximately 15 million patients annually. Includes diagnostic services, dialysis treatments, and general healthcare services.
- Digital Health Solutions: Revenue from scaling AI-driven innovations and digital health technologies to healthcare providers and institutions worldwide, including pathology diagnostics and health information systems.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Mubadala Health product offering
Product offeringCore offering
Mubadala Health operates an integrated tech-enabled healthcare platform through M42, providing medical services across 480 facilities in 27 countries serving 15 million patients annually. The company delivers care through four platforms: Global Patient Care (clinical services across 100+ service lines), Digital Health Solutions (AI-driven healthcare technology), Integrated Health Solutions (population health programs), and AI Life Sciences (drug discovery). It also operates diagnostic services through National Reference Laboratory and genomics initiatives via IROS and Abu Dhabi Biobank.
Product overview
M42 operates as a tech-enabled health company offering four integrated platform services: Global Patient Care (operates 480 clinics across 27 countries serving 15 million patients annually), Digital Health Solutions (AI-driven digital health innovations), Integrated Health Solutions (population health and national programs), and AI Life Sciences (AI-powered drug discovery and space health). Supporting these platforms are specialized sub-brands including IROS (genomics-driven clinical trials) and the National Reference Laboratory (diagnostic services with AI-powered pathology). The company positions itself as the #1 largest healthcare company in the Middle East and #3 largest dialysis provider globally.
Differentiator
Problem solved
Functional benefit
Brands
- Global Patient Care: Leading healthcare organization integrating UAE and international assets, operating 480 clinics across 27 countries, serving 15 million patients annually.
- Digital Health Solutions
- Integrated Health Solutions
- AI Life Sciences
- IROS
- Abu Dhabi Biobank
- National Reference Laboratory (NRL)
- Amana Healthcare Bahrain
Products and services
- Global Patient Care
Quantifiable outcome
- 15 million patients served annually
- +3 more outcomes
Companies that use Mubadala Health
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Mubadala Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Mubadala Health partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered flagship and core.
- Department of Health – Abu DhabiflagshipCollaboration on Emirati Genome Programme to enable the UAE's first genomics-driven clinical trial for Alzheimer's prevention. The partnership leverages population genomic data for early identification and disease prevention, advancing precision medicine initiatives in the UAE.
- BioTwincoreStrategic partnership between Abu Dhabi Biobank and BioTwin to expand Human Virtual Twin technology in the UAE. This collaboration supports advanced simulation capabilities for personalized medicine and drug testing using virtual human biology models.
- RCSI Bahrain (Royal College of Surgeons in Ireland - Bahrain)coreMOU between Amana Healthcare Bahrain and RCSI Bahrain to support Bahrain's specialist healthcare through expanded clinical training and research pathways. Medical students gain access to real-world care environments at Amana Healthcare facilities.
- QritivecoreNational Reference Laboratory (NRL), part of M42, collaborated with Qritive (digital pathology innovator) to introduce UAE breakthrough in AI-powered prostate cancer diagnostics, enhancing diagnostic accuracy and speed.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Mubadala Health competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Mubadala Health social profiles
Digital presenceMubadala Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mubadala Health leadership team
Management profileNumber of profiles
Mubadala Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mubadala Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mubadala Health
What does Mubadala Health do?
Mubadala Health operates an integrated tech-enabled healthcare platform through M42, providing medical services across 480 facilities in 27 countries serving 15 million patients annually. The company delivers care through four platforms: Global Patient Care (clinical services across 100+ service lines), Digital Health Solutions (AI-driven healthcare technology), Integrated Health Solutions (population health programs), and AI Life Sciences (drug discovery). It also operates diagnostic services through National Reference Laboratory and genomics initiatives via IROS and Abu Dhabi Biobank.
Is Mubadala Health a public or private company?
Mubadala Health is a private company. It is classified as state government owned and is currently operating.
When was Mubadala Health founded?
Mubadala Health was founded in 2021. It employs 1,001 to 5,000 people.
Where is Mubadala Health based?
Mubadala Health is headquartered in Abu Dhabi, United Arab Emirates, in the Middle East region.
How does Mubadala Health make money?
Two revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are digital Health Solutions.
Does Mubadala Health have an API?
No public API is recorded for Mubadala Health.
What industry is Mubadala Health in?
Mubadala Health's product category is Integrated Healthcare Services. Its primary akta.pro industry code is BPAMAHAH, Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing), with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 6221 and its SIC code is 8000.